He’s Eligible, but Still Waiting: Breaking Down Barriers to Oxybate Access - CME - Guideline Central

CME

Title
He’s Eligible, but Still Waiting: Breaking Down Barriers to Oxybate Access
Link
Description
Despite the fact that oxybates are an established standard of care for narcolepsy, clinicians frequently encounter extended treatment delays. In their focused discussion, narcolepsy experts Alon Avidan, MD, MPH, and David Plante, MD, PhD, explore the root causes of these delays, specifically the fragmented management of the Risk Evaluation and Mitigation Strategy (REMS) and insurance prior authorization processes. Learners will hear operational strategies that synchronize these administrative workflows in parallel to reduce the lag in oxybate initiation. By improving the clinical team’s competence in administrative navigation, this activity transforms the oxybate-prescribing process from a source of frustration to an opportunity for successful patient advocacy and improved practice.
Target Audience
The activity is designed for US-based clinicians (eg, physicians, nurse practitioners [NPs], and physician associates [PAs]) who diagnose or treat central disorders of hypersomnolence (CDH), including clinicians who specialize in sleep medicine, neurology, psychiatry, or pulmonology.
Learning Objectives
  • Apply strategies to overcome barriers to the use of oxybates for narcolepsy, including REMS and insurance requirements, controlled substance restrictions, abuse potential, safety risks, dosing inconvenience, and drug-drug interactions.
Estimated Duration
15 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Psychiatry, Pulmonology, Neurology, Sleep Medicine
Keywords
narcolepsy
Disclosures and Disclaimers
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education or Avadel CNS Pharmaceuticals, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Accredited Providers
  • Haymarket Medical Education
Commercial Support
  • Avadel CNS Pharmaceuticals, LLC
Activity Expiration Date
April 3, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit0.25 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.